Wuyi Pharma (HKG:1889) 2011 net profit RMB57M, down 46%; div HK$0.008 - ResearchInChina

Search by Type

Report Charts News

*

Search by Company

Code Company name

Category

Home>>News>>Life Sciences>>Biotechnology>>Biopharmaceutical

Remember Me Next Time

Wuyi Pharma (HKG:1889) 2011 net profit RMB57M, down 46%; div HK$0.008

Date:2012-03-29

Related Company

Wuyi International Pharmaceutical Company Limited(01889.HK)

Results of Wuyi International Pharmaceutical Company (HKG:1889) for the fiscal year ended 31 December 2011:

Net profit: RMB56.87M, down 46.32% YoY
EPS: RMB 3.3 cents
Final dividend: HK$0.008

Source:chinesestock.org

Welcome to our website. This service is open to member only.

Registration

Contact our customer service team
Tel: 86-10-82600828, 82600893
Fax: 86-10-82601570
Email: report@researchinchina.com

Related Reports

China Heparin Industry Report, 2010-20112011-09-28
China Blood Products Industry Report, 2010-20112011-09-05
China Monoclonal Antibody Industry Report, 2010-20112011-07-05
China Insulin Industry Report, 20102011-01-25
China Heparin Industry Report, 20102010-12-18
China Blood Products Industry Report, 20102010-11-10
Global and China Biopharmaceutical Industry Report, 20102010-09-16
China Blood Products Industry Report, 20092009-10-13

Related News

Wuyi Pharma (HKG:1889) 2011 net profit RMB57M, down 46%; div HK$0.0082012-03-29
Lijun (HKG:2005) sinks to red, 2011 NL $41M; div 2 ct2012-03-26
Walvax Biotechnology 2011 Earnings Up 34.40%, Shares Slide2012-03-15
Fudan-Zhangjiang (HKG:8231) Sees 2011 Net Profit Up Sharply2012-02-13
Clinical trial completed for Melanoma2012-02-10
Quintiles launches new capabilities for success in Asia2012-02-09
Acorda Therapeutics launches Zanaflex Capsules2012-02-08
Novozymes wins Technology Innovation award2012-02-06

Contact us | Copyright | Privacy policy | Buy Reports | Member Service | Mailing List

2005-2011 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1